Horrible markets for biotechsApart from Thera's stock being a total s..t show, these markets for small cap and biotech specilally are something of historical proportions. Thera lived trough 30 years of being public and wend to 12$ a couple of times for no good reason and to 19 cents for better ones but this time whatever the outcome of the pipeline, well it's plain absurdity. I have to agree with our friend going ape sh t about shorts, trolls and market manipulator. The company used to have supporters like the Caisse and good retail base that made every past episodes less painful. This time around they scrapped any relation that was left with their long time retail shareholders and the Big boys ain't showing lot of support for their cause by the way we keep loosing 5% o 10% on a 25k volume. It's part markets, market participants but on the other hand they haven't managed to put in place an adequate base of large shareholders to back them in difficult times. Working on a buyout on the cheap is not the same as long term beleivers.